Cancer Drug Boosts Levels of Vascular-Protective Gene, KLF2
Case Western Reserve UniversityCase Western Reserve University researchers have discovered that an existing drug, bortezomib (Velcade), has been shown to help prevent clot development. Lalitha Nayak, MD, an assistant professor of medicine, reports in the June 12 edition of the journal Blood, the anti-thrombotic effects of bortezomib are determined by KLF2.